ArticleScientific reports2020

Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy.

Santiago Delgado-Tirado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.